What this means
Mitochondrial dysfunction, characterized by increased oxidative stress, impaired energy metabolism, disrupted mitochondrial dynamics, abnormal quality control, and activation of apoptosis, represents a critical pathological basis for a wide range of aging-related diseases (ARDs), including neurodegenerative diseases, cardiovascular disorders, sarcopenia, and osteoarthritis. Mitochondria-targeted drug delivery systems increase the effective concentration of bioactive molecules within these dysfunctional organelles, offering novel strategies for the precise modulation of mitochondrial function.
A plain-English summary is on its way. Until then, this is the start of the authors' own summary.
- Who it was tested in
- Earlier studies
- Kind of research
- A summary of earlier studies
The science
- Original title
- Mitochondria-targeted drug delivery systems for aging-related diseases: Mechanisms, strategies, and advances.
- Authors
- Zhang F, Ma H, Zhou S et al.
- Journal
- Journal of controlled release : official journal of the Controlled Release Society
- Published
- Oct 16, 2026
- Study type
- Review
- PMID
- 42887605 ↗
Abstract
Mitochondrial dysfunction, characterized by increased oxidative stress, impaired energy metabolism, disrupted mitochondrial dynamics, abnormal quality control, and activation of apoptosis, represents a critical pathological basis for a wide range of aging-related diseases (ARDs), including neurodegenerative diseases, cardiovascular disorders, sarcopenia, and osteoarthritis. Mitochondria-targeted drug delivery systems increase the effective concentration of bioactive molecules within these dysfunctional organelles, offering novel strategies for the precise modulation of mitochondrial function. This review summarizes structural and functional changes in mitochondria during aging and their associations with major ARDs. We comprehensively review key advances in the design principles, mechanisms of action, and applications of passive targeting, stimuli-responsive systems, active targeting, and biomimetic drug delivery platforms. In addition, emerging interventions such as NAD+ supplementation, mitochondrial gene delivery, EV-mediated mitochondrial delivery and mitochondrial transplantation are discussed. Despite the demonstrated potential of these systems to restore mitochondrial homeostasis and tissue functionality in various disease models, their clinical translation remains constrained by obstacles including unstable targeting efficacy under pathological conditions, insufficient long-term safety of materials, manufacturing complexity, and a lack of standardized evaluation criteria. Future efforts should focus on integrating disease heterogeneity, advanced materials, and multi-omics technologies to advance mitochondria-targeted therapies toward standardization, individualization, and diagnostic-therapeutic integration.
Zhang F, Ma H, Zhou S et al. Mitochondria-targeted drug delivery systems for aging-related diseases: Mechanisms, strategies, and advances. Journal of controlled release : official journal of the Controlled Release Society. 2026. doi:10.1016/j.jconrel.2026.115463. PMID: 42887605. https://pubmed.ncbi.nlm.nih.gov/42887605/
Related research
Two drugs together eased stroke brain damage in mice
Researchers gave mice two compounds, alone and together, after a stroke-like injury to the brain. The mice given both had less brain damage and better nerve function than those given either one alone.
Mitochondrial Quality Control in Degenerative Musculoskeletal Diseases: Signaling Networks and Therapeutic Landscapes.
Degenerative musculoskeletal disorders, including osteoarthritis (OA), intervertebral disc degeneration (IVDD), and osteoporosis (OP), are increasingly viewed as disorders of mitochondrial quality control (MQC) rather…
Targeting of Protein Persulfidation in Aging and Age-Related Disorders.
Aging is associated with a progressive loss of proteostasis and increased susceptibility to neurodegenerative and metabolic disorders.
Eye supplements that target aging pathways: a review of current evidence
This review looked at vitamins and similar products for eye diseases tied to aging. It says early signs look promising, but long-term benefit is not yet proven.
SIRT1-Redox Crosstalk in Aging: Adaptive Capacity and Cellular State Transitions.
Aging gradually reduces the ability of cells to maintain and restore homeostasis under metabolic and oxidative stress.
Nicotinamide Mononucleotide-Producing Probiotic Strain B12-N Attenuates Aging and Cognitive Decline in a Caenorhabditis elegans Model of Alzheimer's Disease:…
Nicotinamide mononucleotide (NMN) is an active component found in probiotics that may help alleviate Alzheimer's disease and the effects of aging.
See all research on NAD+ boosters →